In line with these results, the ongoing AID activity is enriched in higher risk U-CLL cases (228), and the contribution of subclonal aberrations to CLL pathogenesis is being increasingly recognized (232). This evidence concerns the gene AICDA and B-cell chronic lymphocytic leukemia.